Refractive surgery device market set to grow in US
This article was originally published in Clinica
Boosted by the introduction of new technology, the $64 million US refractive surgery device market is predicted to show strong growth of 72% over the next 12 months, according to a new report from marketing consultants Frost & Sullivan.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.